CIK 0001723128 · Large accelerated filer
Amneal Pharmaceuticals, Inc.
Sign in to watch- Ticker
- AMRX
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Entity type
- operating
- Phone
- (908) 947-3120
- Former names
- Atlas Holdings, Inc.
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Reading 13 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2020-02-27 | Branning Todd P. SVP and CFO | Grant or award · Restricted Stock Units | +83,113 | 83,113 | ||
| 2020-02-27 | Branning Todd P. SVP and CFO | Grant or award · Performance-Based Restricted Stock Units | +166,226 | 166,226 | ||
| 2020-02-27 | BOYER ANDREW S Exec VP, Comm Optns | Grant or award · Restricted Stock Units | +126,649 | 126,649 | ||
| 2020-02-27 | BOYER ANDREW S Exec VP, Comm Optns | Grant or award · Performance-Based Restricted Stock Units | +253,298 | 253,298 | ||
| 2020-01-22 | Branning Todd P. SVP and CFO | Option exercise | +20,096 | 20,096 | ||
| 2020-01-22 | Branning Todd P. SVP and CFO | Shares withheld for taxes | −7,311 | $5.13 | $38K | 12,785 |
| 2020-01-22 | Branning Todd P. SVP and CFO | Option exercise · Restricted Stock Units | −20,096 | 60,290 | ||
| 2020-01-03 | BUCHEN DAVID A SVP, Chief Legal Officer | Option exercise | +27,614 | 28,614 | ||
| 2020-01-03 | BUCHEN DAVID A SVP, Chief Legal Officer | Shares withheld for taxes | −8,188 | $4.72 | $39K | 20,426 |
| 2020-01-03 | BUCHEN DAVID A SVP, Chief Legal Officer | Option exercise · Restricted Stock Units | −27,614 | 82,843 | ||
| 2019-12-14 | Yanai Shlomo Director | Grant or award · Stock Option | +28,506 | 28,506 | ||
| 2019-12-14 | Yanai Shlomo Director | Grant or award · Restricted Stock Units | +7,522 | 7,522 | ||
| 2019-12-14 | George Jeffrey P. Director | Grant or award · Restricted Stock Units | +7,522 | 7,522 | ||
| 2019-12-14 | George Jeffrey P. Director | Grant or award · Stock Option | +28,506 | 28,506 | ||
| 2019-12-14 | Kiely John Director | Grant or award · Stock Option | +28,506 | 28,506 | ||
| 2019-12-14 | Kiely John Director | Grant or award · Restricted Stock Units | +7,522 | 7,522 | ||
| 2019-11-13 | Todisco Joseph SVP, Specialty Commercial | Returned to the company · Stock Option | −72,661 | 0 | ||
| 2019-11-13 | Todisco Joseph SVP, Specialty Commercial | Grant or award · Stock Option | +72,661 | 72,661 | ||
| 2019-11-13 | Todisco Joseph SVP, Specialty Commercial | Returned to the company · Stock Option | −90,498 | 0 | ||
| 2019-11-13 | Todisco Joseph SVP, Specialty Commercial | Grant or award · Stock Option | +90,498 | 90,498 |
Page 36 of 43 · 846 trades